GID BIO CELLULAR IMPLANT TECHNOLOGY
Introducing an innovative platform technology that provides cellular therapy for multiple significant indications.
GID TECHNOLOGY OVERVIEW
Our modular tissue processing platform enables point-of-care therapy for a broad range of indications. By reducing an entire GMP cell-processing facility to a single disposable device, physicians can extract and process adipose tissue in real time using proven scientific methods, controls and reagents. This platform provides scalable cell processing for hospitals, medical practices and other surgical or clinical settings.
Cellular Implant Benefits
- Repeatable and predictable
- Alternative to invasive surgical or drug treatments
GID BIO technology is revolutionizing medicine in three therapeutic domains: musculoskeletal, dermal and organ. There is potential for numerous clinical applications utilizing our cellular implants.
Osteoarthritis (OA) knee
OA hip/Avascular necrosis (AVN)
OA small joints
Anterior cruciate ligament (ACL) knee
Peripheral vascular disease
(PVD) small vessel
PVD large vessel
Chronic obstructive pulmonary disease (COPD)
Eyes (Dry eye)
Erectile dysfunction (ED)
Our clinical pipeline features targeted therapeutic applications and clinical development in three primary therapeutic domains.
GID clinical trials are in progress for numerous therapeutic applications. Click the links below for further information on specific applications.
Osteoarthritis: A multisite pivotal clinical trial that is double blinded, randomized, placebo controlled, dose escalated and statistically powered.
Alopecia: An exploratory clinical trial to assess initial safety and feasibility of SVF for hair regeneration in patients with hair loss.
Erectile Dysfunction: A safety and feasibility clinical trial to assess use of SVF for treatment of erectile dysfunction.
COPD: An exploratory clinical trial to assess initial safety and feasibility of SVF for treatment of chronic obstructive pulmonary disease .